DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe
COPENHAGEN, Denmark, 30 December 2021 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby communicate and comment on the intention from the new government of Germany to legalize controlled sales of cannabis for adults for recreational purposes. The German government estimates that the state can earn 4.7 billion euros (approximately DKK 35 billion) annually on a legalization.The value of the global illegal cannabis market is estimated by Fortune Business to be worth at least the equivalent of DKK 130 billion. The German